"10.1371_journal.pone.0054741","plos one","2013-01-30T00:00:00Z","Eliza Wyszko; Maciej Szymański; Heinz Zeichhardt; Florian Müller; Jan Barciszewski; Volker A Erdmann","Institute of Bioorganic Chemistry of the Polish Academy of Sciences, Poznan, Poland; Charite - University Medicine Berlin, Campus Benjamin Franklin, Institute for Virology, Berlin, Germany; Pentafolium-Soft, Rosengarten, Germany; Institute for Chemistry and Biochemistry, Free University Berlin, Berlin, Germany","Prepared the human serum donated by a Berlin patient and participated in the discussions of the results: HZ. Developed and designed the three dimensional models for the mirror image ribozymes interacting with the mirror image targets: FM. Conceived and designed the experiments: VAE. Performed the experiments: EW. Analyzed the data: EW MS JB VAE. Contributed reagents/materials/analysis tools: HZ FM. Wrote the paper: VAE JB FM.","The authors have the following patent applications: “Pharmazeutische Zusammensetzung zur Behandlung von Nebenwirkungen durch Gabe von Spiegelmeren” PCT/DE 2010/00159; “Pharmazeutische Zusammensetzung enthaltend L-DNA” DE 10 2010 056 610.1; and “Spiegelselektion und Spiegelevolution von Nukleinsäuren” PCT/EP 97/04726. One author (FM) is the owner of the Pentafolinum-Soft company and he is collaborating with all coauthors on the 3D modeling of Spiegelzymes. There are no further patents, products in development or marketed products to declare. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.","2013","01","Eliza Wyszko","EW",6,TRUE,1,1,4,3,TRUE,TRUE,FALSE,0,NA,FALSE
